Please log in
You must be logged in to send the contact request.
Manage stand orders
Select Option
Efferon JSC/JV
Skolkovo Innovation Center Ter., 7 Nobel,
143026
Moscow
Russian Federation
Russian Federation
Submit your contact details
Provide your contact details to the exhibitor. Optionally, you may also add a personal message.
Your name, phone number, and e-mail address are subject to the submission of personal data. Messe Düsseldorf GmbH expressly points out that for a data transmission into third countries, for which no adequacy decision of the EU-commission is on hand certifying an adequate level of protection of personal data, it is not ensured that there are appropriate safeguards for the protection of personal data on hand.
An error has occurred
Please check your internet connection or try again later.
Message has been sent
Your message to the exhibitor was sent successfully.
This company is co-exhibitor of
Moscow Export Center ANPO
Contact
Ivan Bessonov
Our range of products
Product categories
- 01 Electromedical equipment / medical technology
- 01.06 Intense medicine / anesthesiology / respiration
- 01.06.07 Other equipment for intense medicine / anesthesiology / respiration
Other equipment for intense medicine / anesthesiology / respiration
Our products
Product category: Other equipment for intense medicine / anesthesiology / respiration
Efferon LPS - extracorporeal blood adsorber
Single-use therapeutic device for extracorporeal blood purification. Contains LPS-selective polymeric adsorbent beads.
Device is intended for extracorporeal purification of blood by adsorption of endogenous and exogenous toxic substances using a sterile cylinder filled with polymeric adsorbent.
Efferon LPS is a non-pyrogenic, gamma-sterilized, single-use device.
Extracorporeal blood purification adsorbent device Efferon LPS is a cylindrical column filled with spherical granules of LPS-selective polymeric adsorbent. It is used for direct hemoperfusion to selectively remove bacterial endotoxins (lipopolysaccharides) and excess of cytokines and inflammatory mediators.
Efferon LPS is used in resuscitation and intensive care units.
Indications for use
– Sepsis of verified or suspected gram-negative aetiology, including septic shock during infectious processes in the gastrointestinal tract, respiratory organs, excretory system, skin and soft tissues, angiogenic sepsis;
– Destructive diseases of internal organs leading to LPS translocation and endotoxemia: severe acute pancreatitis, peritonitis, antibiotic-associated colitis, pneumonia, meningitis;
– Any diseases and conditions occurring with acute mesenteric ischemia: mesenteric thrombosis, post resuscitation disease, visceral circulation disorders, postoperative period in vascular surgery, reperfusion syndrome post cardiac surgery.
Device is intended for extracorporeal purification of blood by adsorption of endogenous and exogenous toxic substances using a sterile cylinder filled with polymeric adsorbent.
Efferon LPS is a non-pyrogenic, gamma-sterilized, single-use device.
Extracorporeal blood purification adsorbent device Efferon LPS is a cylindrical column filled with spherical granules of LPS-selective polymeric adsorbent. It is used for direct hemoperfusion to selectively remove bacterial endotoxins (lipopolysaccharides) and excess of cytokines and inflammatory mediators.
Efferon LPS is used in resuscitation and intensive care units.
Indications for use
– Sepsis of verified or suspected gram-negative aetiology, including septic shock during infectious processes in the gastrointestinal tract, respiratory organs, excretory system, skin and soft tissues, angiogenic sepsis;
– Destructive diseases of internal organs leading to LPS translocation and endotoxemia: severe acute pancreatitis, peritonitis, antibiotic-associated colitis, pneumonia, meningitis;
– Any diseases and conditions occurring with acute mesenteric ischemia: mesenteric thrombosis, post resuscitation disease, visceral circulation disorders, postoperative period in vascular surgery, reperfusion syndrome post cardiac surgery.
Product category: Other equipment for intense medicine / anesthesiology / respiration
Efferon CT - extracorporeal blood adsorber
Single-use therapeutic device for extracorporeal blood purification. Contains anti-cytokine polymeric adsorbent beads.
Device is intended for extracorporeal purification of blood by adsorption of endogenous and exogenous toxic substances using a sterile cylinder filled with polymeric adsorbent.
Efferon CT is a non-pyrogenic, gamma-sterilized, single-use device.
Extracorporeal blood purification column Efferon CT is a cylindrical column filled with spherical granules of anti-cytokine polymeric adsorbent. It is used for direct hemoperfusion to remove the excess of cytokines and inflammatory mediators.
Efferon LPS is used in resuscitation and intensive care units.
Indications for use
· Systemic inflammatory response syndrome, “cytokine storm” syndrome.
· Rhabdomyolysis.
· Elevated levels of cytokines and/or myoglobin.
Device is intended for extracorporeal purification of blood by adsorption of endogenous and exogenous toxic substances using a sterile cylinder filled with polymeric adsorbent.
Efferon CT is a non-pyrogenic, gamma-sterilized, single-use device.
Extracorporeal blood purification column Efferon CT is a cylindrical column filled with spherical granules of anti-cytokine polymeric adsorbent. It is used for direct hemoperfusion to remove the excess of cytokines and inflammatory mediators.
Efferon LPS is used in resuscitation and intensive care units.
Indications for use
· Systemic inflammatory response syndrome, “cytokine storm” syndrome.
· Rhabdomyolysis.
· Elevated levels of cytokines and/or myoglobin.
About us
Company details
Efferon JSC is a biomedical technology company, specializing in polymeric adsorbents and therapeutic devices.
Our first two products are single-use therapeutic devices for extracorporeal blood purification devices for endotoxin and cytokines removal.
Indications are:
- sepsis and septic shock
- multiple organ failure syndrome
- "cytokine storm" syndrome
These products were approved for clinical use one year ago in Russia and currently we are presented in all Russian ICUs (see our products presentation attached). We have our own R&D and production center in Moscow, Russia.
Currently we are focused on establishing our export sales and are looking for local partners.
Our first two products are single-use therapeutic devices for extracorporeal blood purification devices for endotoxin and cytokines removal.
Indications are:
- sepsis and septic shock
- multiple organ failure syndrome
- "cytokine storm" syndrome
These products were approved for clinical use one year ago in Russia and currently we are presented in all Russian ICUs (see our products presentation attached). We have our own R&D and production center in Moscow, Russia.
Currently we are focused on establishing our export sales and are looking for local partners.